Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation

W Dekant1

  • 1Institut für Toxikologie, Universität Würzburg, Germany.

Toxicology Letters
|April 1, 1993
PubMed

Insights

Glutathione S-conjugates from certain chemicals can form toxic metabolites, primarily targeting the kidney. This review details their formation, toxicity, and implications for human risk assessment.

Area of Science:

  • Toxicology
  • Biochemistry
  • Environmental Health

Background:

  • Glutathione conjugate formation is a known pathway for generating toxic metabolites from various chemical classes.
  • Halogenated alkenes, hydroquinones, and quinones are key examples of compounds metabolized via glutathione conjugation.
  • The kidney is frequently identified as the primary target organ for these toxic metabolic pathways.

Purpose of the Study:

  • To review the current knowledge on the biosynthesis and toxicity of glutathione S-conjugates.
  • To discuss the mechanisms by which these conjugates lead to toxic metabolites.
  • To explore the factors influencing kidney susceptibility and human risk assessment.

Main Methods:

  • Literature review and synthesis of existing research on glutathione S-conjugates.
  • Analysis of biochemical pathways involved in the bioactivation of glutathione conjugates.
  • Examination of toxicological data and epidemiological studies related to target organ toxicity.

Main Results:

  • Two main types of toxic glutathione conjugates identified: those converted to toxic metabolites and those acting as transport forms for toxic quinones.
  • The kidney's capacity to accumulate and bioactivate intermediates of S-conjugate processing explains its selective toxicity.
  • Various factors influencing renal susceptibility and human risk assessment have been elucidated.

Conclusions:

  • Glutathione S-conjugate formation is a critical toxicological pathway with significant implications for kidney damage.
  • Understanding these pathways is essential for accurate human risk assessment of exposed populations.
  • Further research into modulating factors could lead to improved protective strategies.

Related Concept Videos

Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...